The Administrative Core will handle the managerial and clerical duties for the three Projects and three Cores. It will be responsible for manuscript and figure preparation, organizing paperwork for abstracts, and scheduling of travel for all Program Project Grant personnel. It will organize centralized radiation disposal for the program's participants. It will organize the meetings of the Internal and External Advisory Committees. It will serve as a central resource office for the Organization of the Program Project Grant in terms of scheduling meetings every month for formalized discussion of the Program's progress. The office will serve as a liaison with the appropriate business offices of the University of Cincinnati Department of Physiology and the Division of Molecular Cardiovascular Biology, in order to integrate personnel and financial matters within the Program. The Core will serve as the liaison point for interactions with the appropriate offices at the NHLBI, as well as being a responsive point of contact for the special needs of the Program's participants. It will keep central records needed by the Program's Director so that timely Progress Reports can be prepared. It will keep a central database of breeding for the various mouse colonies in order to ensure that an overall accurate census is maintained. It will keep the central financial records and provide timely reports to the individual Project and Core Leaders with respect to their spending. Ms. Mary Gulick and files will be housed in the Children's Hospital Research Foundation in Room 3331 of the New Research Building. Ms. Gulick is the Business Manager for the Division of Molecular Cardiovascular Biology. She currently serves as the main administrative support staff for the current PPG as part of her responsibilities here at The Children's Hospital. She is located on the same floor as the Program Director. The Core's duties will be divided equally among the Projects.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL069779-10
Application #
8374763
Study Section
Special Emphasis Panel (ZHL1-PPG-D)
Project Start
Project End
2013-08-31
Budget Start
2012-01-01
Budget End
2012-12-31
Support Year
10
Fiscal Year
2012
Total Cost
$69,896
Indirect Cost
$23,299
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Robbins, Jeffrey (2017) Oliver Smithies, DPhil: 1925-2017. Circ Res 120:1535-1536
Travers, Joshua G; Kamal, Fadia A; Valiente-Alandi, Iñigo et al. (2017) Pharmacological and Activated Fibroblast Targeting of G??-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression. J Am Coll Cardiol 70:958-971
Schafer, Allison E; Blaxall, Burns C (2017) G Protein Coupled Receptor-mediated Transactivation of Extracellular Proteases. J Cardiovasc Pharmacol 70:10-15
Xiang, Fu-Li; Fang, Ming; Yutzey, Katherine E (2017) Loss of ?-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice. Nat Commun 8:712
Singh, Sonia R; Zech, Antonia T L; Geertz, Birgit et al. (2017) Activation of Autophagy Ameliorates Cardiomyopathy in Mybpc3-Targeted Knockin Mice. Circ Heart Fail 10:
Khalil, Hadi; Maillet, Marjorie; Molkentin, Jeffery D (2017) Spatial Gene Profiling in the Ischemic Heart: Fibroblasts Put on Their SOX. Circulation 136:1410-1411
Tallquist, Michelle D; Molkentin, Jeffery D (2017) Redefining the identity of cardiac fibroblasts. Nat Rev Cardiol 14:484-491
Rudomanova, Valeria; Blaxall, Burns C (2017) Targeting GPCR-G??-GRK2 signaling as a novel strategy for treating cardiorenal pathologies. Biochim Biophys Acta 1863:1883-1892
Kamal, Fadia A; Travers, Joshua G; Schafer, Allison E et al. (2017) G Protein-Coupled Receptor-G-Protein ??-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure. J Am Soc Nephrol 28:197-208
McLendon, Patrick M; Davis, Gregory; Gulick, James et al. (2017) An Unbiased High-Throughput Screen to Identify Novel Effectors That Impact on Cardiomyocyte Aggregate Levels. Circ Res 121:604-616

Showing the most recent 10 out of 127 publications